Verve Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Verve Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Verve Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $79.9M, a 8.18% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $79.9M -$7.12M -8.18% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $81.7M -$7.03M -7.92% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $83.5M -$6.48M -7.2% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $85.3M -$6.58M -7.16% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $87M -$4.29M -4.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $88.8M +$87.9M +10480% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $90M +$88.7M +6617% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $91.9M +$90M +4896% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $91.3M +$89M +3811% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $839K Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.34M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.84M +$1.84M Dec 31, 2021 10-K 2023-03-02
Q3 2021 $2.34M Sep 30, 2021 10-Q 2021-11-10
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.